ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Expression of BCR-ABL in HSCs leads to a disease resembling chronic phase CML in experimental animals, suggesting that this oncogene is enough to explain the early chronic phase of the disease [31,32].